Previous 10 | Next 10 |
Becton, Dickinson, and Company (NYSE:BDX) has selected "embecta" as the name for its Diabetes Care business which will become an independent, publicly-traded company after the completion of its previously announced spinoff. Post-spinoff, embecta will be led by CEO Devdatt (Dev) Kurdikar, as p...
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. For further details see: Dividend Champion, Contender, An...
Monthly update of the Dividend Champions List. 75 companies declared higher dividends in the past month, with an average increase of 8.55% over their previous payouts. Eight new Contenders, and two new Challengers. For further details see: Dividend Champions For December...
All stocks have at least five fiscal years of dividend growth history and come from the U.S. Dividend Champions List. They have an average increase of 11.9% and a median increase of 5.4%. YTD, I've tracked 479 increases. There are 11 increases for next week, down from 29 last week...
Becton, Dickinson (NYSE:BDX) announced the acquisition of Venclose, Inc., a company that offers therapeutic options for patients with chronic venous insufficiency (CVI). CVI, a result of malfunctioning valves that can lead to varicose veins, affects an estimated 40% of women and 17% of men in...
BD Acquires Venclose, Inc. To Extend Treatment Innovations In Chronic Venous Disease - Acquisition marks BD's entry point to the treatment of Chronic Venous Insufficiency -- adding transformative solutions to its existing venous disease portfolio with the potential to reshape pa...
BD Issues 2021 Global Inclusion, Diversity and Equity Report Progress Builds Strong Foundation for Bold 2030+ ESG Goals to Advance the World of Health for All PR Newswire FRANKLIN LAKES, N.J. , Dec. 1, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (...
BD Statement on Testing for the COVID-19 Omicron Variant of Concern PR Newswire FRANKLIN LAKES, N.J. , Nov. 30, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following state...
Even after the dip on Black Friday NOBL is still having a positive return in November. I present 3 strategies that theoretically can beat the dividend aristocrat index in the long term. One strategy is beating NOBL in November thus far, however, two strategies remain ahead of NOBL...
BD Names Dr. Joseph M. Smith as Chief Scientific Officer Digital Health Pioneer to Focus on External Innovation; Becomes Co-Chair of BD Scientific Advisory Board PR Newswire FRANKLIN LAKES, N.J. , Nov. 29, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Compan...
News, Short Squeeze, Breakout and More Instantly...
Becton Dickinson and Company Company Name:
BDX Stock Symbol:
NYSE Market:
Becton Dickinson and Company Website:
BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases PR Newswire Collaboration on Flow Cytometry-Based Companion Diagnostics to Advance Personalized Health Care FRANKLIN LAKES, N.J. and SECAUCUS, N.J. , July 25, 20...
2024-07-11 12:00:00 ET July 11, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the second of a two-part series looking at recent news and developments in the blood infections treatment market, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:C...
BD Statement on Supplier Issue Impacting BD BACTEC™ Blood Culture Vials PR Newswire Company Committed to Support Global Health and Customers BD Taking all Available Measures to Mitigate Supplier Issue FRANKLIN LAKES, N.J. , July 10 , 2024...